Indiana Hemophilia & Thrombosis Center, Inc.Indianapolis, IN, USAIndianapolis, Indiana, United States
PB0182 - Results from the Hypoplasminogenemia International retroSpecTive and prOspective cohoRt studY (HISTORY) on plasminogen deficiency
Sunday, June 23, 202413:45 – 14:45 ICT
OC 30.5 - Efficacy and safety of fidanacogene elaparvovec in adults with moderately severe or severe hemophilia B: updated results from the phase 3 BENEGENE-2 gene therapy trial
Monday, June 24, 202410:30 – 10:45 ICT
